# Named Patient Program With Rotigotine Transdermal System

> **NCT01095484** · — · COMPLETED · sponsor: **UCB Pharma** · enrollment: 520 (actual)

## Conditions studied

- Conditions for Which There is a Documented Medical Necessity to Receive Treatment With Rotigotine

## Interventions

- **DRUG:** Rotigotine patch

## Key facts

- **NCT ID:** NCT01095484
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 520 (ACTUAL)
- **Last updated:** 2014-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01095484

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01095484, "Named Patient Program With Rotigotine Transdermal System". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01095484. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*